Photocure ASA
Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced ce… Read more
Photocure ASA (PHCUF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.065x
Based on the latest financial reports, Photocure ASA (PHCUF) has a cash flow conversion efficiency ratio of 0.065x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($31.63 Million) by net assets ($484.54 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Photocure ASA - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Photocure ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Photocure ASA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Photocure ASA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Quang Viet Enterprise Co Ltd
TW:4438
|
-0.025x |
|
Galaxy Software Services Corporation
TWO:6752
|
0.042x |
|
Suzhou Goldengreen Technologies Ltd
SHE:002808
|
-0.041x |
|
Samhwa Paint
KO:000390
|
0.003x |
|
Discovery Holdings Ltd
JSE:DSY
|
0.085x |
|
Sanderson Design Group plc
PINK:WKGBF
|
0.018x |
|
Nepes Ark Corp.
KQ:330860
|
0.038x |
|
Semperit Aktiengesellschaft Holding
PINK:SEIGF
|
0.041x |
Annual Cash Flow Conversion Efficiency for Photocure ASA (2002–2024)
The table below shows the annual cash flow conversion efficiency of Photocure ASA from 2002 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $501.72 Million | $76.75 Million | 0.153x | +52.90% |
| 2023-12-31 | $482.85 Million | $48.31 Million | 0.100x | +2394.18% |
| 2022-12-31 | $462.73 Million | $-2.02 Million | -0.004x | -109.18% |
| 2021-12-31 | $502.63 Million | $23.89 Million | 0.048x | +54.94% |
| 2020-12-31 | $508.13 Million | $15.59 Million | 0.031x | -69.03% |
| 2019-12-31 | $208.59 Million | $20.66 Million | 0.099x | +172.38% |
| 2018-12-31 | $176.34 Million | $-24.12 Million | -0.137x | -26.45% |
| 2017-12-31 | $218.08 Million | $-23.59 Million | -0.108x | -242.01% |
| 2016-12-31 | $251.94 Million | $19.19 Million | 0.076x | +176.09% |
| 2015-12-31 | $210.06 Million | $-21.03 Million | -0.100x | -294.80% |
| 2014-12-31 | $240.06 Million | $-6.09 Million | -0.025x | +93.16% |
| 2013-12-31 | $269.12 Million | $-99.72 Million | -0.371x | -156.53% |
| 2012-12-31 | $380.27 Million | $-54.93 Million | -0.144x | -84.12% |
| 2011-12-31 | $439.34 Million | $-34.47 Million | -0.078x | -330.80% |
| 2010-12-31 | $458.85 Million | $15.60 Million | 0.034x | -95.55% |
| 2009-12-31 | $415.78 Million | $317.44 Million | 0.763x | +355.48% |
| 2008-12-31 | $199.69 Million | $-59.68 Million | -0.299x | +18.77% |
| 2007-12-31 | $259.99 Million | $-95.66 Million | -0.368x | -281.35% |
| 2006-12-31 | $326.94 Million | $66.33 Million | 0.203x | +113.94% |
| 2005-12-31 | $48.47 Million | $-70.54 Million | -1.455x | -147.85% |
| 2004-12-31 | $85.57 Million | $-50.25 Million | -0.587x | -9.86% |
| 2003-12-31 | $131.90 Million | $-70.51 Million | -0.535x | -75.36% |
| 2002-12-31 | $167.00 Million | $-50.91 Million | -0.305x | -- |